NP Anagnou

729 total citations
21 papers, 657 citations indexed

About

NP Anagnou is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, NP Anagnou has authored 21 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 12 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in NP Anagnou's work include Hemoglobinopathies and Related Disorders (15 papers), Erythrocyte Function and Pathophysiology (5 papers) and RNA modifications and cancer (4 papers). NP Anagnou is often cited by papers focused on Hemoglobinopathies and Related Disorders (15 papers), Erythrocyte Function and Pathophysiology (5 papers) and RNA modifications and cancer (4 papers). NP Anagnou collaborates with scholars based in United States, Greece and Bulgaria. NP Anagnou's co-authors include Arthur W. Nienhuis, AW Nienhuis, Timothy J. Ley, Guglielmina Pepe, R. Keith Humphries, TJ Ley, Alan N. Schechter, A D Moulton, Gordon Keller and Stefán Karlsson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

NP Anagnou

21 papers receiving 621 citations

Peers

NP Anagnou
Lois B. Wilson United States
Mei‐Chi Cheung United States
Richard A. Voit United States
Mirosława Siatecka United States
P. K�hnl Germany
Anoop K. Sendamarai United States
George Stavrides United Kingdom
Jon Burdach Australia
Lois B. Wilson United States
NP Anagnou
Citations per year, relative to NP Anagnou NP Anagnou (= 1×) peers Lois B. Wilson

Countries citing papers authored by NP Anagnou

Since Specialization
Citations

This map shows the geographic impact of NP Anagnou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by NP Anagnou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites NP Anagnou more than expected).

Fields of papers citing papers by NP Anagnou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by NP Anagnou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by NP Anagnou. The network helps show where NP Anagnou may publish in the future.

Co-authorship network of co-authors of NP Anagnou

This figure shows the co-authorship network connecting the top 25 collaborators of NP Anagnou. A scholar is included among the top collaborators of NP Anagnou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with NP Anagnou. NP Anagnou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Anagnou, NP, Stylianos E. Antonarakis, Stephen J. O’Brien, W.S. Modi, & AW Nienhuis. (1988). Chromosomal localization and racial distribution of the polymorphic human dihydrofolate reductase pseudogene (DHFRP1).. PubMed. 42(2). 345–52. 27 indexed citations
3.
Enver, Tariq, et al.. (1988). Developmental programs of human erythroleukemia cells: globin gene expression and methylation.. Molecular and Cellular Biology. 8(11). 4917–4926. 25 indexed citations
4.
Lin, Henry J., NP Anagnou, T. R. Rutherford, Takashi Shimada, & Arthur W. Nienhuis. (1987). Activation of the human beta-globin promoter in K562 cells by DNA sequences 5' to the fetal gamma- or embryonic zeta-globin genes.. Journal of Clinical Investigation. 80(2). 374–380. 30 indexed citations
5.
Anagnou, NP, Stylianos E. Antonarakis, Stephen J. O’Brien, & Arthur W. Nienhuis. (1987). A novel form of human polymorphism involving the hDHFR-ψ1pseudogene identifies three RFLPs. Nucleic Acids Research. 15(13). 5501–5501. 2 indexed citations
7.
Anagnou, NP, Stefán Karlsson, A D Moulton, Gordon Keller, & Arthur W. Nienhuis. (1986). Promoter sequences required for function of the human gamma globin gene in erythroid cells.. The EMBO Journal. 5(1). 121–126. 54 indexed citations
9.
10.
Papayannopoulou, T, Dale Lindsley, S. Kurachi, et al.. (1985). Adult and fetal human globin genes are expressed following chromosomal transfer into MEL cells.. Proceedings of the National Academy of Sciences. 82(3). 780–784. 18 indexed citations
11.
14.
Anagnou, NP, et al.. (1984). A beta-globin gene, inactive in the K562 leukemic cell, functions normally in a heterologous expression system.. Proceedings of the National Academy of Sciences. 81(14). 4485–4489. 45 indexed citations
16.
Nienhuis, AW, NP Anagnou, & TJ Ley. (1984). Advances in thalassemia research. Blood. 63(4). 738–758. 13 indexed citations
17.
Ley, Timothy J., NP Anagnou, Constance Tom Noguchi, et al.. (1983). DNA methylation and globin gene expression in patients treated with 5-azacytidine.. PubMed. 134. 457–74. 24 indexed citations
18.
Anagnou, NP, Timothy J. Ley, George W. Wright, et al.. (1983). Acquired alpha-thalassemia in preleukemia is due to decreased expression of all four alpha-globin genes.. Proceedings of the National Academy of Sciences. 80(19). 6051–6055. 18 indexed citations
19.
Ley, Timothy J., NP Anagnou, Guglielmina Pepe, & Arthur W. Nienhuis. (1982). RNA processing errors in patients with beta-thalassemia.. Proceedings of the National Academy of Sciences. 79(15). 4775–4779. 138 indexed citations
20.
Fessas, P, et al.. (1980). Glycerol-3-phosphate dehydrogenase activity in the red cells of patients with thalassemia. Blood. 55(4). 564–569. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026